Watch Demo

Hungary Anti Rheumatic Industry Outlook 2022 - 2026

See how Hungary Anti Rheumatic performed compared to key markets such as South Korea, Germany and Spain.

Key Market Indicators

Sales of antirheumatic medicine in Hungary are forecast to drop 6% annually over the next five years, reaching $12.4 million in 2026. Since 2008, the Hungarian market has decreased by an average of 1.8% each year. In 2021, the country ranked 19th, with Latvia in the top spot at $18.2 million. Germany, Spain and Canada took the 2nd, 3rd and 4th spots, respectively.

Marketing Banner

Hungary Anti Rheumatic Market Data and Forecasts

How much will Hungary Anti Rheumatic Market grow to 2026?

Forecast: Quinoline herbicides Sales in Hungary
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Hungary
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Hungary
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Hungary
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Hungary
More in Anti Rheumatic Industry for 2028